Old Web
English
Sign In
Acemap
>
Paper
>
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysis
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysis
2019
Wan-Long Chuang
Tsung Hui Hu
Peter Buggisch
Christophe Moreno
W. W. Su
Luigi Biancone
Robert H. Hyland
Sophia Lu
Svetlana Markova
Hadas Dvory-Sobel
Anu Osinusi
Anuj Gaggar
Cheng Yuan Peng
Chen-Hua Liu
Meghan Sise
Alessandra Mangia
Keywords:
Dialysis
Virology
LEDIPASVIR/SOFOSBUVIR
Diabetes mellitus
Medicine
Internal medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]